» Articles » PMID: 26857018

Mast Cells and Anaphylaxis

Overview
Date 2016 Feb 10
PMID 26857018
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

For half a century, it has been known that the mast cell is the cell responsible for the majority of anaphylactic events. Its mediators, taken as a whole, are capable of producing all of the clinical manifestations of these events. With the discovery of immunoglobulin E (IgE), it was originally felt that the vast majority of anaphylactic episodes were due to antigen coupling with two cell-bound IgE molecules. More recently it has been learned that many episodes are produced by direct activation of mast cells, not involving antigen binding to IgE, and that monomeric IgE under certain conditions can also cause degranulation. Of note--in regard to antigen independent degranulation--are recent reports that the human G-protein-coupled receptor, MRGPRX2, may be the receptor for many drugs and cationic proteins capable of producing direct mast cell degranulation and anaphylactic events.

Citing Articles

Importance of mast cell histamine secretion in IgG-mediated systemic anaphylaxis.

Khodoun M, Strait R, Hall A, Stolfi A, Finkelman F J Allergy Clin Immunol. 2024; 155(3):956-973.

PMID: 39550048 PMC: 11875995. DOI: 10.1016/j.jaci.2024.11.009.


Sensory sentinels: Neuroimmune detection and food allergy.

Matatia P, Christian E, Sokol C Immunol Rev. 2024; 326(1):83-101.

PMID: 39092839 PMC: 11436315. DOI: 10.1111/imr.13375.


Serum MRGPRX2 as a Long-term Biomarker for Iodinated Contrast Media-Induced Anaphylaxis.

An J, Lee C, Kim S, Park S, Kim S, Sim D Allergy Asthma Immunol Res. 2024; 16(3):308-316.

PMID: 38910288 PMC: 11199152. DOI: 10.4168/aair.2024.16.3.308.


Non-IgE-Mediated Immediate Drug-Induced Hypersensitivity Reactions.

Alvarez-Arango S, Kumar M, Chow T, Sabato V J Allergy Clin Immunol Pract. 2024; 12(5):1109-1119.

PMID: 38423288 PMC: 11081849. DOI: 10.1016/j.jaip.2024.02.019.


Synergism between IL-33 and MRGPRX2/FcεRI Is Primarily Due to the Complementation of Signaling Modules, and Only Modestly Supplemented by Prolonged Activation of Selected Kinases.

Franke K, Li Z, Bal G, Zuberbier T, Babina M Cells. 2023; 12(23).

PMID: 38067128 PMC: 10705352. DOI: 10.3390/cells12232700.


References
1.
Patterson R, Fitzsimons E, Choy A, Harris K . Malignant and corticosteroid-dependent idiopathic anaphylaxis: successful responses to ketotifen. Ann Allergy Asthma Immunol. 1997; 79(2):138-44. DOI: 10.1016/S1081-1206(10)63100-6. View

2.
Gordon J, Galli S . Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. Nature. 1990; 346(6281):274-6. DOI: 10.1038/346274a0. View

3.
da Silva E, Jamur M, Oliver C . Mast cell function: a new vision of an old cell. J Histochem Cytochem. 2014; 62(10):698-738. PMC: 4230976. DOI: 10.1369/0022155414545334. View

4.
Akin C, Scott L, Kocabas C, Kushnir-Sukhov N, Brittain E, Noel P . Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis. Blood. 2007; 110(7):2331-3. PMC: 1988935. DOI: 10.1182/blood-2006-06-028100. View

5.
Butterfield J, Weiler C . Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production. Int Arch Allergy Immunol. 2008; 147(4):338-43. DOI: 10.1159/000144042. View